Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels

Autor:	Anthony Dobi, Arthur Dubernet, Mahary Lalarizo Rakoto, Anne-Laure Sandenon Seteyen, Damien Vagner, Grégorie Lebeau, Loïc Raffray, Philippe Gasque
Rok vydání:	2022
Předmět:	Interleukin-6 Immunology Humans HLA-DR Antigens Severity of Illness Index Dexamethasone Monocytes COVID-19 Drug Treatment
Zdroj:	Immunologic Research. 70:714-719
ISSN:	1559-0755 0257-277X
DOI:	10.1007/s12026-022-09269-w
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a9c4f3ebeda1779debfb43e53aff4e https://doi.org/10.1007/s12026-022-09269-w Zobrazit plný text záznamu Full text from SpringerLink